CLINICAL TRIALS PROFILE FOR LOTRISONE
✉ Email this page to a colleague
All Clinical Trials for LOTRISONE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02953184 ↗ | Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy | Unknown status | Jilin University | Phase 2 | 2016-11-01 | The regimen PLD plus cyclophosphamide 4 cycles followed by paclitaxel or docetaxel 4 cycles(noted in phase II CAPRICE) will be used as experimental group. The regimen will be compared to the standard treatment of doxorubicin plus cyclophosphamide(AC) 4 cycles followed by paclitaxel or docetaxel 4 cycles[noted in National Comprehensive Cancer Network (NCCN) guideline]. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LOTRISONE
Condition Name
Clinical Trial Locations for LOTRISONE
Clinical Trial Progress for LOTRISONE
Clinical Trial Phase
Clinical Trial Sponsors for LOTRISONE
Sponsor Name